Related references
Note: Only part of the references are listed.A signature for pan-cancer prognosis based on neutrophil extracellular traps
Yi Zhang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy
Sheng-Kai Geng et al.
BMC CANCER (2021)
Progress and challenges of immunotherapy in triple-negative breast cancer
Yinxing Zhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Interleukin 17A promotes cell migration, enhances anoikis resistance, and creates a microenvironment suitable for triple negative breast cancer tumor metastasis
Yi-Fang Tsai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells
Mio Yamaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
Shuvasree SenGupta et al.
FRONTIERS IN IMMUNOLOGY (2021)
CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
Florence Boissiere-Michot et al.
CANCERS (2021)
Interleukin-17 activates JAK2/STAT3, PI3K/Akt and nuclear factor-κB signaling pathway to promote the tumorigenesis of cervical cancer
Yanfei Bai et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Tumor-associated neutrophils activated by tumor-derived CCL20 (C-C motif chemokine ligand 20) promote T cell immunosuppression via programmed death-ligand 1 (PD-L1) in breast cancer
Louis Boafo Kwantwi et al.
BIOENGINEERED (2021)
Increased number of intratumoral IL-17+cells, a harbinger of the adverse prognosis of triple-negative breast cancer
Xiao-Long Qian et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
MEGF11 is related to tumour recurrence in triple negative breast cancer via chemokine upregulation
Jen-Hwey Chiu et al.
SCIENTIFIC REPORTS (2020)
Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer
Yu Zhang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
Chong Shuai et al.
FRONTIERS IN ONCOLOGY (2020)
Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis
Ryotaro Ogawa et al.
CLINICAL CANCER RESEARCH (2019)
IL-17A promotes CXCR2-dependent angiogenesis in a mouse model of liver cancer
Liguo Liu et al.
MOLECULAR MEDICINE REPORTS (2019)
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop
Ying Wang et al.
CLINICAL CANCER RESEARCH (2019)
Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells
Sen Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Neutrophil extracellular traps in breast cancer and beyond: current perspectives on NET stimuli, thrombosis and metastasis, and clinical utility for diagnosis and treatment
Hunter T. Snoderly et al.
BREAST CANCER RESEARCH (2019)
Th17 cells regulate the production of CXCL1 in breast cancer
Kai Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis
Xin Qian et al.
CYTOKINE (2017)
IL-17 Promotes Neutrophil-Mediated Immunity by Activating Microvascular Pericytes and Not Endothelium
Rebecca Liu et al.
JOURNAL OF IMMUNOLOGY (2016)
IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment
Luciana Benevides et al.
CANCER RESEARCH (2015)
Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer
Simone Punt et al.
ONCOIMMUNOLOGY (2015)
Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
T. Xiang et al.
ONCOGENE (2015)
Intratumor IL-17-Positive Mast Cells Are the Major Source of the IL-17 That Is Predictive of Survival in Gastric Cancer Patients
Xiaosun Liu et al.
PLOS ONE (2014)
Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor
Wen-Chung Chen et al.
HISTOPATHOLOGY (2013)
Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma
Fang-Ming Gu et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Targeting IL-17and TH17 cells in chronic inflammation
Pierre Miossec et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
Jiankun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma
Fang-Ming Gu et al.
MOLECULAR CANCER (2011)
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Reiko M. Onishi et al.
IMMUNOLOGY (2010)
IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence
Shyamasree Datta et al.
JOURNAL OF IMMUNOLOGY (2010)
Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Xi Chen et al.
LUNG CANCER (2010)
The role of chemokines in neutrophil biology
Yoshiro Kobayashi
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis
M Numasaki et al.
JOURNAL OF IMMUNOLOGY (2005)
Increased elastase and myeloperoxidase activity associated with neutrophil recruitment by IL-17 in airways in vivo
H Hoshino et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Share Paper
